60 related articles for article (PubMed ID: 5845354)
1. [National investigation of the therapeutic use of rifamycin SV with the help of the Argentine medical profession].
Gindin LR; Carozzi MR
Prensa Med Argent; 1965 Jun; 52(22):1391-8. PubMed ID: 5845354
[No Abstract] [Full Text] [Related]
2. [Rifamycin SV in the therapy of tuberculosis].
Covacev L; Monzali G
Clin Ter; 1966 Dec; 39(6):547-66. PubMed ID: 5999285
[No Abstract] [Full Text] [Related]
3. [The use of rifamycin SV as a method of venous perfusion in tuberculotics with liver diseases].
Zanotelli F
Fracastoro; 1965; 58(6):427-38. PubMed ID: 5863724
[No Abstract] [Full Text] [Related]
4. [Experimentation with rifamycin SV by perfusion in pulmonary tuberculosis resistant to classic therapies].
Despierres G; Viallier J; Robillard J; Chapuy H; Perrot H
Lyon Med; 1966 May; 215(18):1235-45. PubMed ID: 5932317
[No Abstract] [Full Text] [Related]
5. [Use of rifamycin SV in the local treatment of pulmonary tuberculosis in resistant or initially severe cases].
Tricoire J; Yannicopoulos MC
Rev Tuberc Pneumol (Paris); 1965 Dec; 29(12):1071-6. PubMed ID: 5865572
[No Abstract] [Full Text] [Related]
6. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2.
Fattinger K; Cattori V; Hagenbuch B; Meier PJ; Stieger B
Hepatology; 2000 Jul; 32(1):82-6. PubMed ID: 10869292
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of therapeutic activity in tuberculosis of rifamycin SV used locally and intravenously].
Moncalvo F; Moreo G
Minerva Med; 1965 Nov; 56(88):3721-7. PubMed ID: 5846624
[No Abstract] [Full Text] [Related]
8. [Therapeutic action of rifomycin SV in chronic osteomyleitis in children. Ptemliminary study].
Sierra Rojas L; Flores A
Gac Med Mex; 1966 Jan; 96(1):69-87. PubMed ID: 6001371
[No Abstract] [Full Text] [Related]
9. [Surface activity of watery solutions of Rifamycin SV].
Florstedt H; Bornschein M; Voigt R
Pharmazie; 1971 Dec; 26(12):779-80. PubMed ID: 5141267
[No Abstract] [Full Text] [Related]
10. [Physio-chemical considerations on a chromatic phenomenon produced by a mixture of rifamycin S and SV in the free acid state].
Curci G; Sarluca F
G Ital Chemioter; 1966; 13(1):27-31. PubMed ID: 5994447
[No Abstract] [Full Text] [Related]
11. [Determination of the biliary elimination time of rifamycin SV during duodenal intubation and its comparison with bromsulphalein].
Laudano OM
Prensa Med Argent; 1965 Dec; 52(48):2983-5. PubMed ID: 5886573
[No Abstract] [Full Text] [Related]
12. Chemotherapeutic activity of new derivatives of rifamycin.
Kradolfer F; Neipp L; Sackmann W
Antimicrob Agents Chemother (Bethesda); 1966; 6():359-64. PubMed ID: 5985258
[No Abstract] [Full Text] [Related]
13. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
Dhople AM; Dimova V
Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
[TBL] [Abstract][Full Text] [Related]
14. [Considerations on the clinical use of rifamycin M 14].
Idéo G
Clin Ter; 1966 Apr; 37(1):35-45. PubMed ID: 5919307
[No Abstract] [Full Text] [Related]
15. [Rifamycin SV and congenital malformations in the chick embryo].
Frontino G
Arch Putti Chir Organi Mov; 1966; 21():302-7. PubMed ID: 5944463
[No Abstract] [Full Text] [Related]
16. [Rifamycin for topical use in auricular diseases].
De Vita C
Arch Ital Laringol; 1965; 73(6):439-44. PubMed ID: 5873067
[No Abstract] [Full Text] [Related]
17. [On the passage into the anterior chamber of rifamycin SV administered by venous perfusion].
Milano C
Boll Soc Ital Biol Sper; 1966 Feb; 42(3):102-4. PubMed ID: 5945185
[No Abstract] [Full Text] [Related]
18. The treatment of acute cholecystitis and other diseases with rifamycin diethylamide (rifamide).
Stratford BC
Med J Aust; 1966 Jan; 1(1):7-9. PubMed ID: 5901862
[No Abstract] [Full Text] [Related]
19. [Experimental research on the organotropism at the maternal and fetal level of rifamycin SV].
Bertè E; Moncalvo F
G Ital Tuberc Mal Torace; 1965; 19(6):248-51. PubMed ID: 5893317
[No Abstract] [Full Text] [Related]
20. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
